Mitsubishi UFJ Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$213K Buy
123,598
+91,199
+281% +$157K ﹤0.01% 972
2025
Q1
$108K Buy
32,399
+2,715
+9% +$9.04K ﹤0.01% 1019
2024
Q4
$227K Buy
29,684
+4,192
+16% +$32.1K ﹤0.01% 973
2024
Q3
$239K Sell
25,492
-2,407
-9% -$22.6K ﹤0.01% 941
2024
Q2
$224K Sell
27,899
-14,906
-35% -$120K ﹤0.01% 951
2024
Q1
$634K Sell
42,805
-1,960
-4% -$29K ﹤0.01% 846
2023
Q4
$354K Buy
44,765
+7,277
+19% +$57.5K ﹤0.01% 954
2023
Q3
$171K Buy
37,488
+2,060
+6% +$9.37K ﹤0.01% 1035
2023
Q2
$249K Sell
35,428
-7,161
-17% -$50.4K ﹤0.01% 1011
2023
Q1
$260K Buy
42,589
+2,574
+6% +$15.7K ﹤0.01% 995
2022
Q4
$244K Buy
40,015
+23,090
+136% +$141K ﹤0.01% 1003
2022
Q3
$162K Buy
16,925
+1,149
+7% +$11K ﹤0.01% 1049
2022
Q2
$174K Sell
15,776
-231
-1% -$2.55K ﹤0.01% 1057
2022
Q1
$267K Buy
16,007
+909
+6% +$15.2K ﹤0.01% 1018
2021
Q4
$288K Sell
15,098
-3,753
-20% -$71.6K ﹤0.01% 1017
2021
Q3
$465K Hold
18,851
﹤0.01% 956
2021
Q2
$491K Buy
18,851
+8,610
+84% +$224K ﹤0.01% 957
2021
Q1
$324K Buy
10,241
+3,633
+55% +$115K ﹤0.01% 945
2020
Q4
$307K Buy
6,608
+1,187
+22% +$55.1K ﹤0.01% 900
2020
Q3
$178K Buy
5,421
+199
+4% +$6.53K ﹤0.01% 907
2020
Q2
$143K Sell
5,222
-2,465
-32% -$67.5K ﹤0.01% 929
2020
Q1
$230K Buy
7,687
+1,380
+22% +$41.3K ﹤0.01% 837
2019
Q4
$161K Sell
6,307
-2,574
-29% -$65.7K ﹤0.01% 908
2019
Q3
$162K Buy
8,881
+1,564
+21% +$28.5K ﹤0.01% 853
2019
Q2
$179K Sell
7,317
-8,805
-55% -$215K ﹤0.01% 842
2019
Q1
$153K Buy
16,122
+748
+5% +$7.1K ﹤0.01% 827
2018
Q4
$137K Buy
15,374
+6,162
+67% +$54.9K ﹤0.01% 800
2018
Q3
$104K Buy
+9,212
New +$104K ﹤0.01% 847